IPO

ANG Lifesciences India Ltd

Public issue of 15,00,800, equity shares of face value of Rs. 10.00 each of ANG Lifesciences India Limited ("ANG" or "ALIL" or "The Company" or "The Issuer") for cash at a price of Rs. 80.00 per equity share (including a share premium of Rs. 70.00 per equity share) ("Issue Price") aggregating to Rs. 12.01 crores ("The Issue") of which, 76,800 equity shares of face value of Rs. 10/- each at a price of Rs. 80.00 per equity share aggregating to Rs. 0.61 crores will be reserved for subscription by market maker ("market maker reservation portion"). The issue less the market maker reservation portion i.e. Issue of 14,24,000 equity shares of face value of Rs. 10.00 each at an issue price of Rs. 80.00 per equity share aggregating to Rs. 11.39 crores is hereinafter referred to as the "net issue". The issue and the net issue will constitute 28.95% and 27.47%, respectively of the post issue paid up equity share capital of the company. The face value of the equity shares is Rs. 10 each and the issue price of Rs. 80.00 is 8 times of the face value.
Issue
Opens On Closes On
29-Aug-17 31-Aug-17
Money Payable On
Application Allotment
80.00 0.00
Minimum Application for shares in Nos : 1600 Further Multiples of : 1600
Cr Lead Managers to the Issue
Project Cost (.Cr) 12.01 Guiness Corporate Advisors Pvt Ltd
Project Financed through Current Offer (.Cr) 12.01  
Post Issue Equity Share Capital (.Cr) 5.18
Issue Price () 80.00
Projects
To meet the working capital requirement
Promoted By
Rajesh Gupta
Saruchi Gupta
Listing At
BSE - SME
Registrar to the Issue
Bigshare Services Pvt Ltd